Eisai China Inc. clinical trials

A country office of Eisai Co., Ltd.

The registry lists 2 studies whose lead sponsor is Eisai China Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Dec 28, 2011.

Status

Completed: 2

Phase

Phase 3: 1

Where

China: 2

Registry sponsor names on this page

Eisai China Inc.2 studies

Something wrong with this grouping? Tell us on the Eisai Co., Ltd. page.

Studies

Recruiting first, then most recently updated. Showing 2 of 2. All Eisai Co., Ltd. studies →

Drug Use Survey (DUS) of Triple Therapy (Methycobal (MBL)+ Myonal (MYO)+ Non-steroidal Anti-inflammatory Drags (NSAID)) on the Symptom Relief of Lumbar DDD in ChinaCompletedNCT01299077
Sponsor listed in the registry: Eisai China Inc.
Efficacy and Safety of Cinitapride Tablets in the Treatment of Mild to Moderate Functional DyspepsiaCompletedNCT01355276Phase 3
Sponsor listed in the registry: Eisai China Inc.